Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy and Safety of Low-dose Oral Isotretinoin for Seborrhea
This study is currently recruiting participants.
Verified October 2011 by Federal University of São Paulo
Study NCT01139749   Information provided by Federal University of São Paulo

First Received on June 1, 2010.   Last Updated on October 9, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Seborrhea
Seborrheic Dermatitis
Quality of Life
Additional conditions recognized in this trial
Dermatitis
Dermatitis, Seborrheic
More general conditions related to this trial
Sebaceous Gland Diseases
Skin Diseases
Skin Diseases, Eczematous
Skin Diseases, Papulosquamous
Interventions listed in this trial
oral isotretinoin
Additional drug interventions recognized in this trial
Ciclopirox
Isotretinoin
Salicylates
Salicylic Acid
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Anti-Infective Agents
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Antifungal Agents
Antirheumatic Agents
Central Nervous System Agents
Cyclooxygenase Inhibitors
Dermatologic Agents
Enzyme Inhibitors
Keratolytic Agents
Molecular Mechanisms of Pharmacological Action
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Federal University of São Paulo


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services